Author:
Krown Susan E.,Paredes Josephine
Reference37 articles.
1. Rabkin CS, Janz S, Lash A, et al.: Monoclonal origin of multicentric Kaposi’s sarcoma lesions. N Engl J Med 1997, 336:988–993.
2. Moore PS, Chang Y: Kaposi’s sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr 1998, 23:65–71.
3. Krown SE: Kaposi’s sarcoma. In Principles and Practice of the Biological Therapy of Cancer, edn 3. Edited by Rosenberg SA. Philadelphia: Lippincott Williams & Wilkins; 2000:256–275.
4. Krown SE: Diagnosis and treatment of AIDS-associated Kaposi’s sarcoma. In AIDS-related Cancers and Their Treatment Edited by Feigal EG, Levine AM, Biggar RJ. New York: Marcel Dekker; 2000:59–95.
5. Gill PS, Wernz J, Scadden DT, et al.: Randomized phase II trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS-related Kaposi’s sarcoma. J Clin Oncol 1996, 14:2353–2364.